Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Phase III Trial Comparing Etoposide/Cisplatin (EP) With Irinotecan/Cisplatin (IP) in Patients With Previously Untreated, Extensive Disease (ED) Small Cell Lung Cancer (SCLC)

NCT00349492 is registered in ClinicalTrials.gov with Clinical Research Center for Solid Tumor, Korea as lead sponsor.

NCT NCT00349492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00349492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Phase III Trial Comparing Etoposide/Cisplatin (EP) With Irinotecan/Cisplatin (IP) in Patients With Previously Untreated, Extensive Disease (ED) Small Cell Lung Cancer (SCLC)
Lead sponsor
Clinical Research Center for Solid Tumor, Korea
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2006
Completion date
October 31, 2013
Enrollment
372 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer